Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 0.09% is 101% above its 5-year average of -10.18%, near the high end of its 5-year range (-754.45%–34.04%).
98.92% below its 12-month average of 8.34%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 34.04%.
OPERATING MARGIN
0.09%
OPERATING MARGIN AVG TTM
8.34%
OPERATING MARGIN AVG 3Y
0.33%
OPERATING MARGIN AVG 5Y
-10.18%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-98.92%
CURRENT VS 3Y AVG
-72.41%
CURRENT VS 5Y AVG
+100.88%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 438 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Eton Pharmaceuticals, Inc.
Market Cap
$1.52B
Operating Margin
0.09%
TTM Avg
8.34%
3Y Avg
0.33%
5Y Avg
-10.18%
Market Cap
$1.46B
Operating Margin
20.42%
TTM Avg
-52.76%
3Y Avg
-545.80%
5Y Avg
-384.16%
Market Cap
$1.45B
Operating Margin
7.03%
TTM Avg
2.87%
3Y Avg
2.90%
5Y Avg
2.58%
Market Cap
$1.43B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.65B
Operating Margin
-5.55%
TTM Avg
-16.51%
3Y Avg
-27.71%
5Y Avg
-34.02%
Market Cap
$1.65B
Operating Margin
15.35%
TTM Avg
4.65%
3Y Avg
1.95%
5Y Avg
-3.05%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eton Pharmaceuticals, Inc. (ETON) | $1.52B | 0.09% | 8.34% | 0.33% | -10.18% |
| GH Research PLC (GHRS)vs › | $1.52B | 0.00% | 0.00% | 0.00% | 0.00% |
| Braveheart Bio, Inc. (BRVE)vs › | $1.51B | N/A | N/A | N/A | N/A |
| Certara, Inc. (CERT)vs › | $1.57B | 1.86% | 2.28% | 0.69% | -0.42% |
| AnaptysBio, Inc. (ANAB)vs › | $1.46B | 20.42% | -52.76% | -545.80% | -384.16% |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.45B | 7.03% | 2.87% | 2.90% | 2.58% |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.43B | 0.00% | 0.00% | 0.00% | 0.00% |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.65B | -5.55% | -16.51% | -27.71% | -34.02% |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.65B | 15.35% | 4.65% | 1.95% | -3.05% |
| Alpha Tau Medical Ltd (DRTS)vs › | $1.34B | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
57.9%
Operating Margin
0.1%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 34.04% |
| 2026-03-31 | 9.95% |
| 2025-12-31 | 11.58% |
| 2025-09-30 | -6.07% |
| 2025-06-30 | -7.79% |
| 2025-03-31 | -2.72% |
| 2024-12-31 | 5.40% |
| 2024-09-30 | 4.93% |
| 2024-06-30 | -32.35% |
| 2024-03-31 | -10.04% |
| 2023-12-31 | -27.25% |
| 2023-09-30 | -7.80% |
| 2023-06-30 | 32.37% |
| 2023-03-31 | -47.78% |
| 2022-12-31 | 12.50% |
| 2022-09-30 | -89.93% |
| 2022-06-30 | -18.21% |
| 2022-03-31 | -233.78% |
| 2021-12-31 | 21.57% |
| 2021-09-30 | -754.45% |
| 2021-06-30 | -75.81% |
| 2021-03-31 | 45.08% |
| 2020-12-31 | -9160.49% |
| 2020-09-30 | 3895.65% |
| 2020-06-30 | -22690.00% |
| 2020-03-31 | -8970.71% |
| 2019-12-31 | -578.65% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | -1510.80% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
